Dennis Alferez-Castro, BSc, PhD

Search results

• 2017

  Interrogating open issues in cancer precision medicine with patient-derived xenografts

  EurOPDX Consortium, Byrne, A. T., Alférez, D. G., Amant, F., Annibali, D., Arribas, J., Biankin, A. V., Bruna, A., Budinská, E., Caldas, C., Chang, D. K., Clarke, R. B., Clevers, H., Coukos, G., Dangles-Marie, V., Eckhardt, S. G., Gonzalez-Suarez, E., Hermans, E., Hidalgo, M., Jarzabek, M. A., & 23 othersde Jong, S., Jonkers, J., Kemper, K., Lanfrancone, L., Mælandsmo, G. M., Marangoni, E., Marine, J-C., Medico, E., Norum, J. H., Palmer, H. G., Peeper, D. S., Pelicci, P. G., Piris-Gimenez, A., Roman-Roman, S., Rueda, O. M., Seoane, J., Serra, V., Soucek, L., Vanhecke, D., Villanueva, A., Vinolo, E., Bertotti, A. & Trusolino, L., 2017, In: Nature Reviews. Cancer.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Malignant Neoplasm 100%
  • Treatment 66%
  • Drug 33%
  • Mouse 33%
  • Clinical Trial 33%